The inventory rollouts align with Delius Pharma's commitment to strengthening its offline presence.
Representational image took during market survey
Delius Group, parent to Delius Pharmaceuticals Pvt. Ltd, is transforming Mumbai's pharma market with its direct distribution model across India's top 20 cities. dispatched Goods worth ₹50 crore to ₹100 crore reports coming for b2c value.
ADVERTISEMENT
Distributors of Delius Pharma in Mumbai have expressed positive feedback regarding the company's smooth inventory rotation. With the onboarding of new distributors, Delius Pharma has dispatched goods worth ₹50 crore to ₹100 crore according to B2C value in the market, as reported by the All-India Pharma Mumbai Distributors Local Association.
The inventory rollouts align with Delius Pharma's commitment to strengthening its offline presence. As the company expands, Mumbai distributors have praised the direct supply chain model, citing its efficiency and reliability.
“Delius Pharma's direct distribution strategy not only ensures timely supply but also allows distributors to focus on promoting products more effectively," a leading distributor in Mumbai shared.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
